Feb 24, 2025 04:12AM Citizens JMP Reiterates Market Outperform Rating on Mirum Pharamceuticals (MIRM)

Nov 7, 2024 04:30PM Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Jun 17, 2024 03:00PM Mirum Pharamceuticals (MIRM) PT Raised to $64 at Citi

Jun 17, 2024 08:41AM Citi Reiterates Buy Rating on Mirum Pharamceuticals (MIRM)

Jun 3, 2024 08:32AM Citi Opens 30-Day Upside Catalyst Watch on Mirum Pharamceuticals (MIRM)

Apr 16, 2024 04:53AM Citi Opens 90-Day Upside Catalyst Watch on Mirum Pharamceuticals (MIRM)

Nov 29, 2022 09:05AM Citi Reiterates Buy Rating on Mirum (MIRM), PT $34, 'Volixibat ICP Trial Discontinued, PSC and PBC Readouts Remain On Track'

Aug 30, 2022 04:01PM Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Sep 2, 2021 05:30PM Mirum Pharmaceuticals to Participate in September Investor Conferences

Dec 9, 2020 09:00AM Mirum Pharmaceuticals and Oberland Capital Announce Up to $210 Million Funding Arrangement

Jan 9, 2020 05:53AM Mirum Pharmaceuticals, Inc. (MIRM) Prices 2.4M Share Common Offering at $20/Sh

Jan 8, 2020 08:15PM Mirum Pharmaceuticals Announces Pricing of Public Offering

Aug 12, 2019 06:16AM Citi Starts Mirum Pharamceuticals (MIRM) at Buy

Jul 18, 2019 06:15AM Mirum Pharmaceuticals, Inc. (MIRM) Prices 5M Share IPO at $15/Sh

Jul 17, 2019 06:33PM Mirum Pharmaceuticals Announces Pricing of Initial Public Offering